Ernst & Young has named Jean-Paul Clozel, founder of Switzerland-based biotech firm Actelion Pharmaceuticals Ltd., as the World Entrepreneur Of The Year 2008. Founded in 1997, Actelion develops small-molecule drugs for the treatment of pulmonary disease.

"Being named Ernst & Young World Entrepreneur Of The Year 2008 is a great honor for me and my team", said Clozel. "To be singled out from such a strong field of entrepreneurs makes us very proud."

"It's amazing how quickly Jean-Paul has built Actelion from nothing to a market capitalization of nearly €4 billion in a highly competitive and complex sector," said Greg Ericksen, Ernst & Young's Global Vice Chair for Strategic Growth Markets. "His vision and passion have enabled him to become one of the biotechnology industry's most recognized global success stories."

Read more here.